专利 Abandoned

RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ

Name: LaoBiz Laos Intellectual Property Database
Creator: LaoBiz

专利「RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ」由 MEDICAGO INC 持有，当前状态为Abandoned，申请号 P/120。LaoBiz 老商通提供老挝知识产权信息检索与企业关联查询。

Patent “RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ” is held by MEDICAGO INC; status: Abandoned. Search Laos IP records on LaoBiz.

申请号 P/120

申请日期 2008-07-11

申请人 MEDICAGO INC

代理机构 Lao Trademark Agency

类别 A01H 5/00 · A61K 35/76 · A61K 39/145 · A61P 31/16 · A61P 37/04 · C07K 14/11 · C12N 15/44 · C12N 15/82 · C12N 7/00 · C12N 7/01

图样

下载

基础信息

类型: 专利
申请号: P/120
状态: Abandoned
申请人: MEDICAGO INC
代理机构: Lao Trademark Agency
申请日期: 2008-07-11
公开/公告日: 2025-09-19
国际分类: A01H 5/00 · A61K 35/76 · A61K 39/145 · A61P 31/16 · A61P 37/04 · C07K 14/11 · C12N 15/44 · C12N 15/82 · C12N 7/00 · C12N 7/01
商品 / 服务: —

办理流程

根据当前状态动态标注

提交申请 2008-07-11
形式审查 进行中
实质审查
公开 2025-09-19
授权

关联分析

LaoBiz 企业数据库联动

类似专利推荐

TRADITIONAL CHINESE MEDICIN EXTRACT, MEDICAMENT, AND DETECTION METHOD THEREFOR 已注册

ການຖອດລະຫັດບິດສະຕຣິມສຽງດ້ວຍຂໍ້ມູນເມຕ້າໃນການຈໍາລອງແຖບສະເປັກຕຣັມທີ່ໄດ້ຮັບການປັບປຸງໃນອົງປະກອບຂອງຕື່ມຂໍ້ມູນຢ່າງໜ້ອຍໜຶ່ງອົງປະກອບ 已注册

ເຄື່່ອງເຂົ້າລະຫັດ ແລະ ຖອດລະຫັດສຽງພ້ອມກັບໂປຣແກຣມຄວາມດັງຂອງສຽງ ແລະ ຂອບເຂດຂອງຂໍ້ມູນແບບເມຕ້າ (ຂໍ້ມູນເມຕາ) 已注册

PHOTOCATALYTIC REACTOR CELL 已注册

COMPOSITE POLYACRYLAMIDE HYDROGEL AND PREPARATION METHOD THEREFOR 已注册

A DEVICE FOR MEASURING JAUNDICE LEVELS 已注册

A METHOD AND SYSTEM FOR THE APPLICATION OF CHEMICAL COMPOUNDS TO NATURAL FIBERS AND TREATED FIBERS OBTAINED THEREFROM 已注册

摘要

A method for synthesizing influenza virus-like particles (VLPs) within a plant or a portion of a plant is provided. The method involves expression of influenza HA in plants and the purification by size exclusion chromatography. The invention is also directed towards a VLP comprising influenza HA protein and plants lipids. The invention is also directed to a nucleic acid encoding influenza HA as well as vectors. The VLPs may be used to formulate influenza vaccines, or may be used to enrich existing vaccines.